Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold

Journal of Medicinal Chemistry
Ha T DoRichard B Silverman

Abstract

Effective delivery of therapeutic drugs into the human brain is one of the most challenging tasks in central nervous system drug development because of the blood-brain barrier (BBB). To overcome the BBB, both passive permeability and efflux transporter liability of a compound must be addressed. Herein, we report our optimization related to BBB penetration of neuronal nitric oxide synthase (nNOS) inhibitors toward the development of new drugs for neurodegenerative diseases. Various approaches, including enhancing lipophilicity and rigidity of new inhibitors and modulating the p Ka of amino groups, have been employed. In addition to determining inhibitor potency and selectivity, crystal structures of most newly designed compounds complexed to various nitric oxide synthase isoforms have been determined. We have discovered a new analogue (21), which exhibits not only excellent potency ( Ki < 30 nM) in nNOS inhibition but also a significantly low P-glycoprotein and breast-cancer-resistant protein substrate liability as indicated by an efflux ratio of 0.8 in the Caco-2 bidirectional assay.

References

Jan 1, 1994·Methods in Enzymology·J M Hevel, M A Marletta
Jan 1, 1995·Annual Review of Physiology·J Garthwaite, C L Boulton
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·L J RomanB S Masters
Jan 29, 1996·FEBS Letters·J D FossettaD Lundell
Oct 19, 1999·Brain Research. Brain Research Reviews·F TorreillesJ Torreilles
May 9, 2000·The Journal of Biological Chemistry·J M PerryM A Marletta
Dec 13, 2000·Brain Research. Brain Research Reviews·J C de la Torre, G B Stefano
Jan 3, 2001·Acta Crystallographica. Section D, Biological Crystallography·M D WinnG N Murshudov
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jul 19, 2005·Nature Reviews. Neuroscience·Wolfgang Löscher, Heidrun Potschka
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·T Geoff G BattyeAndrew G W Leslie
Jul 5, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Anand G PatilAnagha Damre
Apr 11, 2012·Neurotoxicity Research·Derek A DrechselJoseph S Beckman
Apr 27, 2012·Journal of Medicinal Chemistry·David J St Jean, Christopher Fotsch
May 21, 2013·Neurobiology of Disease·David J Nutt, Jim Attridge
Dec 20, 2013·International Journal of Molecular Sciences·Jie LiHossein A Ghanbari
Feb 20, 2014·Chemical Society Reviews·Paramita MukherjeeRichard B Silverman
May 14, 2014·Expert Opinion on Investigational Drugs·Piero BarbantiDavid Della-Morte
Oct 8, 2014·Acta Crystallographica. Section D, Biological Crystallography·Huiying LiThomas L Poulos
Oct 14, 2014·Advances in Pharmacology·Thomas P DavisMargaret E Tome
Dec 17, 2014·Journal of Medicinal Chemistry·Zoran Rankovic
Feb 15, 2012·Neural Regeneration Research·Xueping ChenJiming Kong
Sep 8, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Judit MüllerGyörgy T Balogh
Jan 23, 2016·Nature Reviews. Drug Discovery·William A Banks
Jan 27, 2017·Neural Regeneration Research·Cristina Maccallini, Rosa Amoroso
Feb 9, 2017·Acta Crystallographica. Section D, Structural Biology·Dorothee LiebschnerPaul D Adams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K D MullenA J McCullough
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Shinsuke Nakagawa, Masami Niwa
© 2022 Meta ULC. All rights reserved